Estrogen and PARP inhibitor combination for advanced ER+ breast cancer shows promise in preclinical models
Advanced estrogen receptor-positive (ER+) breast cancer can be especially difficult to treat. A new study by researchers at Dartmouth Cancer Center led by Todd W. Miller, Ph.D., shows promise in using a combination of estrogen ...
Jul 13, 2023
0
6